Share-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2026

Share-Based Compensation [Abstract]

Schedule of Options Granted

The following table contains additional information on options granted under the 2019 Plan:

		Three months ended June 30,
		2026								2025
		Number of options				Weighted average exercise price				Number of options				Weighted average exercise price
Outstanding at beginning of period			177,960			$	102.09				191,754				80.7
Forfeited and expired			-			$	-				(334	)			65.7
Outstanding at end of period			177,960			$	102.09				191,420				80.7
Exercisable at end of period			174,596			$	80.01				159,561				83.4

Non-vested at beginning of period			3,364			$	3,364				32,010				66.75
Vested			-			$	-				-				-
Forfeited			-			$	-				(150	)			48.15
Non-vested at the end of period			3,364			$	3,364				31,860				66.9

		Six months ended June 30,
		2026								2025
		Number of options				Weighted average exercise price				Number of options				Weighted average exercise price
Outstanding at beginning of period			182,547			$	80.45				193,201			$	80.55
Granted			-							$	-			$	-
Forfeited and expired			(4,587	)		$	102.09				(1,781	)		$	63.75
Outstanding at end of period			177,960			$	79.89				191,420			$	80.7
Exercisable at end of period			174,596			$	80.01				159,561			$	83.4

Non vested at beginning of period			3,364			$	3,364				38,799			$	65.7
Granted			-			$	-				-			$	-
Forfeited and expired			-			$	-				(1,030	)		$	54.75
vested			-			$	-				(5,975	)		$	61.05
Outstanding at end of period			3,364			$	3,364				31,794			$	66.9

Schedule of Exercise Prices and Remaining Contractual Life

c)

Set forth below is data regarding the range of exercise prices and remaining contractual life (in years) for options outstanding at June 30, 2026:

Exercise price				Number of options outstanding				Remaining contractual Life (in years)				Intrinsic Value of Options Outstanding				No. of options exercisable
												(in thousands)
$	21.30				1,000				8			$	-				250
$	40.35				6,021				0.68				-				6,021
$	40.35				37,191				7.51				-				37,191
$	48.15				14,075				7.63				-				14,075
$	54.95				16,667				3.84				-				16,667
$	70.20				1,936				3.75				-				1,936
$	80.10				9,641				5.75				-				9,641
$	80.10				29,271				6.38				-				29,157
$	89.51				10,000				6.38				-				7,500
$	93.30				2,746				1.50				-				2,746
$	93.30				22,112				7.51				-				22,112
$	122.85				10,000				7.51				-				10,000
$	151.80				162				2.37				-				162
$	151.80				406				7.51				-				406
$	183.40				16,667				4.91				-				16,667
$	321.00				65				7.51				-				65
					177,960							$	-				174,596

Schedule of Restricted Stock Units Granted

d)

The following table contains information concerning restricted stock units granted under the 2019 Plan:

		Three months ended June 30,
		2026								2025
		Number of shares				Weighted average grant date fair value				Number of shares				Weighted average grant date fair value
Nonvested at beginning of period			28,672			$	14.75				78,290			$	17.25
Vested			-			$	-				(229	)		$	154.2
Forfeited			-			$	-				(433	)		$	24.15
Nonvested at end of period			28,672			$	14.75				77,628			$	17.1

		Six months ended June 30,
		2026								2025
		Number of shares				Weighted average grant date fair value				Number of shares				Weighted average grant date fair value
Nonvested at beginning of period			145			$	21.15				82,305			$	26.55
Granted			442,054			$	15.54				-			$	-
Vested			(413,527	)		$	15.6				(2,844	)		$	146.1
Forfeited			-			$	-				(1,832	)		$	28.5
Nonvested at end of period			28,672			$	14.75				77,629			$	22.05

Schedule of Share-Based Compensation Expense

e)

The following table summarizes share-based compensation expenses related to grants under the 2019 Plan included in the statements of operations:

		Three months ended June 30,								Six months ended June 30,
(in thousands)		2026				2025				2026				2025
Research & development		$	114			$	111			$	196			$	246
General & administrative			44				184				6,544				342
Total		$	158			$	295			$	6,740			$	588